Insider trades
Tolga Tanguler, Director of Lexeo Therapeutics LXEO, has filed 0 purchases and 119 sales on the open market. Over the past 12 months that comes to a net sale of $3.1M. The latest trade was on 06/25.
Tolga Tanguler
Director
- Company
- Lexeo Therapeutics LXEO
- First filing
- 23/03/01
- Trades
- 146 trades
- Buys / sales
- 0 / 119
- 12-month net buying
- −$3.1M
- Last trade
- 06/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ALNY | Open-market sale | 03/04 | 03/06 | 2,309 sh8 trades | $323.08avg. | $745,983.83 | −6.3% |
ALNY | Open-market sale | 03/02 | 03/04 | 1,598 sh10 trades | $327.65avg. | $523,583.78 | −4.2% |
| Open-market sale | 02/13 | 02/17 | 1,959 sh | $310.08 | $607,446.72 | −5.8% | |
ALNY | Open-market sale | 01/12 | 01/14 | 1,510 sh21 trades | $362.87avg. | $547,927.38 | −4.8% |
ALNY | Open-market sale | 25/10/02 | 25/10/03 | 1,405 sh12 trades | $452.05avg. | $635,126.28 | −4.9% |
ALNY | Open-market sale10b5-1 plan | 25/08/29 | 25/09/02 | 3,474 sh6 trades | $448.37avg. | $1,557,649.44 | −11.8% |
ALNY | Open-market sale | 25/08/18 | 25/08/19 | 1,396 sh8 trades | $453.27avg. | $632,758.71 | −4.5% |
ALNY | Open-market sale | 25/03/03 | 25/03/05 | 471 sh6 trades | $243.78avg. | $114,820.42 | −1.7% |
ALNY | Open-market sale | 25/02/28 | 25/03/03 | 513 sh8 trades | $241.68avg. | $123,983.1 | −3.5% |
ALNY | Open-market sale | 24/11/26 | 24/11/27 | 1,469 sh5 trades | $250.98avg. | $368,685.86 | −10.0% |
ALNY | Open-market sale | 24/06/25 | 24/06/26 | 1,605 sh12 trades | $231.00avg. | $370,747.09 | −12.1% |
ALNY | Open-market sale | 24/02/28 | 24/02/29 | 501 sh5 trades | $155.30avg. | $77,805.43 | −8.7% |
ALNY | Open-market sale | 24/02/16 | 24/02/20 | 1,009 sh3 trades | $148.06avg. | $149,396.69 | −19.9% |
ALNY | Open-market sale | 23/04/27 | 23/04/28 | 1,476 sh5 trades | $194.59avg. | $287,214.96 | −45.0% |
ALNY | Open-market sale | 23/02/02–23/02/03 | 23/02/03 | 5,025 sh9 trades | $230.19avg. | $1,156,692.06 | −100.0% |
